American Society of Clinical Oncology (ASCO) shared a post on X:
“Though the potential therapeutic effects of cannabis are relevant for patients with cancer, clinicians must weigh the symptomatic benefits against emerging cardiopulmonary risks. Timothy M. Pawlik, Zayed Rashid, Erin Stevens discuss for ASCO Daily News here.”
Other articles from ASCO on OncoDaily.